NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Accenture (ACN) was downgraded at UBS to neutral from buy and given a $77 price target. The stock has a rich multiple and is no longer a tech standout, said UBS.
Bed Bath & Beyond (BBBY) was upgraded at Bank of America/Merrill Lynch to buy. $82 price target. Company deserves a higher multiple and estimates were also boosted, BofA/Merrill said.
Citizens Community Bancorp (CZWI) was downgraded to hold at TheStreet Ratings.Owens Corning (OC) was downgraded at Citigroup to neutral from buy and given a $43 price target. Roofing EBIT expectations have been reduced, Citi said. Lihua International (LIWA) was downgraded to hold at TheStreet Ratings. Palo Alto (PANW) was initiated with an outperform rating at Oppenheimer. $47 price target. Company should benefit from solid trends in the security market, Oppenheimer said. Verisk Analytics (VRSK) was initiated with a buy rating at Deutsche Bank. $65 price target. Company has low volatility and can deliver solid organic growth, Deutsche Bank said.
STOCK COMMENTS/EPS CHANGESAccenture numbers were cut at Citigroup. Estimates were reduced given the outlook guide-down, said Citigroup. Given the higher cash balance, however, the price target was raised to $84.50, Citi added. Accenture estimates, price target were reduced at Jefferies. Shares are now seen reaching $71. Estimates were also cut, given the company's new guidance, Jefferies said. Hold rating. KB Home (KBH) price target and estimates were increased at UBS. Earnings estimates were raised on margin outperformance and great-than-expected average selling price growth, said UBS. Price target goes to $14. KB Home estimates were increased at JMP Securities through 2014. Company is realizing higher gross margins, JMP Securities said. Market Perform rating. Lorillard (LO) numbers were raised at Citigroup. Encouraging fundamentals of analog and e-cigarettes, said Citigroup. Price target goes to $46. Nike (NKE) estimates were cut at UBS. Earnings estimates were reduced given the shift in expenses and lower-than-expected share buybacks, said UBS. Paychex (PAYX) numbers were reduced at UBS. Minimal leverage and a difficult demand backdrop, said UBS. Walgreen (WAG) estimates were lowered at Credit Suisse through 2014. Underlying fundamentals remain lackluster, Credit Suisse said. Neutral rating and $45 price target. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV